Neonatal Kabuki Syndrome Caused by KMT2D Mutation: A Case Report

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2023 Dec 20

PMID 38115267

Authors

Zhang Li

Zou Ning

Affiliations

Soon will be listed here.

Abstract

Background: Kabuki syndrome (KS) is an autosomal dominant inherited syndrome that involves multiple organs and systems. Gene mutation is the main cause of KS. The reported mutations in X-linked histone H3 lysine 4 methylase (KMT2D) and KDM6A genes are 2 relatively clear pathogenic pathways. In this paper, we report a case of KS with neonatal hypoglycemia and special features caused by KMT2D gene mutation confirmed by whole exome sequencing, it enriched the clinical phenotype spectrum and gene mutation spectrum of KS, which helps to improve the understanding of the disease.

Case Report: Through whole exome sequencing, we performed gene diagnosis of a newborn child with special facial features and multiple malformations, which revealed heterozygous mutation of NM_003482.3:c.755dupA(p.His252Glnfs*21) in KMT2D gene. It is consistent with the pathogenesis of KS, an autosomal dominat genetic disease caused by KMT2D gene mutation. This pathogenic mutation has not been prebiously reported.

Discussion: KS has strong clinical characteristics and biological heterogeneity. Genetic diagnosis can help identify mutant gene types. However, the relationship between genotype and phenotype has not been fully clarified. The molecular etiological mechanism still needs to be further explored and elucidated.

References

Lintas C, Persico A . Unraveling molecular pathways shared by Kabuki and Kabuki-like syndromes. Clin Genet. 2017; 94(3-4):283-295. DOI: 10.1111/cge.12983. View

Micale L, Augello B, Maffeo C, Selicorni A, Zucchetti F, Fusco C . Molecular analysis, pathogenic mechanisms, and readthrough therapy on a large cohort of Kabuki syndrome patients. Hum Mutat. 2014; 35(7):841-50. PMC: 4234006. DOI: 10.1002/humu.22547. View

Schott D, Stumpel C, Klaassens M . Hypermobility in individuals with Kabuki syndrome: The effect of growth hormone treatment. Am J Med Genet A. 2018; 179(2):219-223. PMC: 6590336. DOI: 10.1002/ajmg.a.60696. View

Yang X, Zeng Y, Xiong F . [Kabuki syndrome case report]. Zhonghua Er Ke Za Zhi. 2011; 48(11):868-70. View

So P, Luk H, Yu K, Cheng S, Hau E, Ho S . Clinical and molecular characterization study of Chinese Kabuki syndrome in Hong Kong. Am J Med Genet A. 2020; 185(3):675-686. DOI: 10.1002/ajmg.a.62003. View

Teranishi H, Koga Y, Nakashima K, Morihana E, Ishii K, Sakai Y . Cancer Management in Kabuki Syndrome: The First Case of Wilms Tumor and a Literature Review. J Pediatr Hematol Oncol. 2018; 40(5):391-394. DOI: 10.1097/MPH.0000000000001111. View

Silva-Andrade N, Lopez-Ortega K, Gallottini M . Orofacial features and medical profile of eight individuals with Kabuki syndrome. Med Oral Patol Oral Cir Bucal. 2019; 24(5):e630-e635. PMC: 6764705. DOI: 10.4317/medoral.22982. View

Lederer D, Grisart B, Digilio M, Benoit V, Crespin M, Ghariani S . Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome. Am J Hum Genet. 2011; 90(1):119-24. PMC: 3257878. DOI: 10.1016/j.ajhg.2011.11.021. View

Ko H, Kim G, Lee H, Kim H, Sung S . Coarctation of the aorta and left ventricular diverticulum in Kabuki syndrome. Pediatr Int. 2019; 61(2):200-201. DOI: 10.1111/ped.13740. View

10.

Cuvertino S, Hartill V, Colyer A, Garner T, Nair N, Al-Gazali L . A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndrome. Genet Med. 2020; 22(5):867-877. PMC: 7200597. DOI: 10.1038/s41436-019-0743-3. View

11.

Ng S, Bigham A, Buckingham K, Hannibal M, McMillin M, Gildersleeve H . Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet. 2010; 42(9):790-3. PMC: 2930028. DOI: 10.1038/ng.646. View

12.

Almecija A, Perez V, Baro M, Guerra-Garcia P, Vivanco J . Atypical Autoimmune Hematologic Disorders in a Patient With Kabuki Syndrome. J Pediatr Hematol Oncol. 2018; 41(2):e114-e115. DOI: 10.1097/MPH.0000000000001182. View

13.

Niikawa N, Matsuura N, Fukushima Y, Ohsawa T, Kajii T . Kabuki make-up syndrome: a syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency. J Pediatr. 1981; 99(4):565-9. DOI: 10.1016/s0022-3476(81)80255-7. View

14.

Van Laarhoven P, Neitzel L, Quintana A, Geiger E, Zackai E, Clouthier D . Kabuki syndrome genes KMT2D and KDM6A: functional analyses demonstrate critical roles in craniofacial, heart and brain development. Hum Mol Genet. 2015; 24(15):4443-53. PMC: 4492403. DOI: 10.1093/hmg/ddv180. View

15.

Bjornsson H, Benjamin J, Zhang L, Weissman J, Gerber E, Chen Y . Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome. Sci Transl Med. 2014; 6(256):256ra135. PMC: 4406328. DOI: 10.1126/scitranslmed.3009278. View

16.

Caciolo C, Alfieri P, Piccini G, Digilio M, Lepri F, Tartaglia M . Neurobehavioral features in individuals with Kabuki syndrome. Mol Genet Genomic Med. 2018; 6(3):322-331. PMC: 6014453. DOI: 10.1002/mgg3.348. View

17.

Banka S, Lederer D, Benoit V, Jenkins E, Howard E, Bunstone S . Novel KDM6A (UTX) mutations and a clinical and molecular review of the X-linked Kabuki syndrome (KS2). Clin Genet. 2014; 87(3):252-8. DOI: 10.1111/cge.12363. View

18.

Dentici M, Barresi S, Niceta M, Pantaleoni F, Pizzi S, Dallapiccola B . Clinical spectrum of Kabuki-like syndrome caused by HNRNPK haploinsufficiency. Clin Genet. 2017; 93(2):401-407. DOI: 10.1111/cge.13029. View

19.

Miyake N, Mizuno S, Okamoto N, Ohashi H, Shiina M, Ogata K . KDM6A point mutations cause Kabuki syndrome. Hum Mutat. 2012; 34(1):108-10. DOI: 10.1002/humu.22229. View

20.

Lepri F, Cocciadiferro D, Augello B, Alfieri P, Pes V, Vancini A . Clinical and Neurobehavioral Features of Three Novel Kabuki Syndrome Patients with Mosaic KMT2D Mutations and a Review of Literature. Int J Mol Sci. 2017; 19(1). PMC: 5796032. DOI: 10.3390/ijms19010082. View